Combined liver resection and radiofrequency ablation for colorectal liver metastases;Kombineret leverresektion og radiofrekvensablation af kolorektale levermetastaser

Ugeskrift for Laeger

Volumn 170, Issue 16, 2008, Pages 1338-1341

  Kannerup, Anne Sofie ^a   Nielsen, Dennis Tønner ^b   Sørensen, Sten Mellerup ^b   Mortensen, Frank Viborg ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; COLORECTAL TUMOR; FEMALE; FOLLOW UP; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 42949147672     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nørgaard M, Iversen LH, Sørensen HT. Kolorektal cancer. Ugeskr Læger 2005;167:4157-9.
2. Burcharth F, Jensen BV. Behandling af lever- og lungemetastaser fra kolorektal cancer. Ugeskr Læger 2005;167:4268-72.
3. Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 2007;11:1057-77.
4. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.
5. Goldberg RM, Sargent DJ, Morton RF et al. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J Clin Oncol 2006;24:3347-53.
6. Pawlik TM, Izzo F, Cohen DS et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003;10:1059-69.
7. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005;30:419-26.
8. Vogl TJ, Straub R, Eichler K et al. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004;230:450-8.
9. Sørensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007;48:253-8.
10. Couinaud CM. A simplified method for controlled left hepatectomy. Surgery 1985;97:358-61.
11. Abdalla EK, Adam R, Bilchik AJ et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271-80.
12. Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-25.
13. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-66.
14. Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 1995;32:333-421.
15. Fioole B, Jansen MC, van Duijnhoven FH et al. Combining partial liver resection and local ablation of liver tumours: a preliminary Dutch experience. World J Surg Oncol 2006;4:46.
16. Saltz LB, Cox JV, Blanke C et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-14.
17. Saltz LB, Meropol NJ, Loehrer PJ et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 2004;22:1201-8.
18. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-33.
19. Mulier S, Ni Y, Jamart J et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158-71.